SOURCE: Medical News Today
DATE: October 25, 2007
EXCERPT: "CardioVascular BioTherapeutics, Inc. (OTCBB: CVBT) has published a brochure authored by CVBT co-founder and cardiovascular surgeon Dr. Thomas Stegmann, titled "Holding a Woman's Heart in My Hands." The informative booklet addresses the unique medical issues women's heart disease presents in both diagnosis and treatment, and how angiogenesis-the growth of new blood vessels in the heart-could be a new medical therapy to treat this disease, which kills more than 480,000 women a year, according to the American Heart Association. .... The informative pamphlet will be distributed at the American Heart Association's Go Red for Women Luncheon, to be held February 27, 2008 at the Four Season's Hotel in Las Vegas, Nevada." more
RELATED LINKS:
Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, Laham RJ, Li W, Pike M, Sellke FW, Stegmann TJ, Udelson JE, Rosengart TK. Clinical trials in coronary angiogenesis: issues, problems, consensus: An expert panel summary.Circulation. 2000 Sep 12;102(11):E73-86. Review.
Stegmann TJ, Hoppert T, Schneider A, Gemeinhardt S, Kocher M, Ibing R, Strupp G. [Induction of myocardial neoangiogenesis by human growth factors. A new therapeutic approach in coronary heart disease]. Herz. 2000 Sep;25(6):589-99. Review. German.
Stegmann, Thomas J. (2005). New Vessels for the Heart: Angiogenesis as New Treatment for Coronary Heart. Henderson, NV: CardioVascular BioTherapeutics Inc. 113 p. ISBN: 0976558300. Publisher book Info. WorldCat.org.
The first scientific steps and 13-year journey that led to current human clinical trials of FGF-1.